These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 35057013

  • 1. Physicochemical Stability of a Novel Tacrolimus Ophthalmic Formulation for the Treatment of Ophthalmic Inflammatory Diseases.
    Barrieu M, Chennell P, Yessaad M, Bouattour Y, Wasiak M, Jouannet M, Le Basle Y, Sautou V.
    Pharmaceutics; 2022 Jan 04; 14(1):. PubMed ID: 35057013
    [Abstract] [Full Text] [Related]

  • 2. Stability of Ophthalmic Atropine Solutions for Child Myopia Control.
    Berton B, Chennell P, Yessaad M, Bouattour Y, Jouannet M, Wasiak M, Sautou V.
    Pharmaceutics; 2020 Aug 17; 12(8):. PubMed ID: 32824572
    [Abstract] [Full Text] [Related]

  • 3. Stability of an ophthalmic micellar formulation of cyclosporine A in unopened multidose eyedroppers and in simulated use conditions.
    Chennell P, Delaborde L, Wasiak M, Jouannet M, Feschet-Chassot E, Chiambaretta F, Sautou V.
    Eur J Pharm Sci; 2017 Mar 30; 100():230-237. PubMed ID: 28131754
    [Abstract] [Full Text] [Related]

  • 4. Stability of an ophthalmic formulation of polyhexamethylene biguanide in gamma-sterilized and ethylene oxide sterilized low density polyethylene multidose eyedroppers.
    Bouattour Y, Chennell P, Wasiak M, Jouannet M, Sautou V.
    PeerJ; 2018 Mar 30; 6():e4549. PubMed ID: 29682408
    [Abstract] [Full Text] [Related]

  • 5. Do Ophthalmic Solutions of Amphotericin B Solubilised in 2-Hydroxypropyl-γ-Cyclodextrins Possess an Extended Physicochemical Stability?
    Chennell P, Yessaad M, Abd El Kader F, Jouannet M, Wasiak M, Bouattour Y, Sautou V.
    Pharmaceutics; 2020 Aug 19; 12(9):. PubMed ID: 32825121
    [Abstract] [Full Text] [Related]

  • 6. Physicochemical and microbiological stability of insulin eye drops in an artificial tear vehicle used in the treatment of refractory neurotrophic keratopathy.
    Le Nguyen MH, Naoum MS, Andre C, Lethier L, Limat S, Fagnoni-Legat C, Guillaume Y, Gauthier AS.
    J Fr Ophtalmol; 2022 Oct 19; 45(8):860-871. PubMed ID: 35914962
    [Abstract] [Full Text] [Related]

  • 7. Stability of tacrolimus ophthalmic solution.
    Ezquer-Garin C, Ferriols-Lisart R, Alós-Almiñana M.
    Am J Health Syst Pharm; 2017 Jul 01; 74(13):1002-1006. PubMed ID: 28645998
    [Abstract] [Full Text] [Related]

  • 8. Stability of 5% vancomycin ophthalmic solution prepared using balanced salt solution after freezing for 90 days.
    Roura-Turet J, Rodriguez-Reyes M, Guerrero-Molina L, Soy-Muner D, López-Cabezas C.
    Am J Health Syst Pharm; 2021 Jul 22; 78(15):1444-1447. PubMed ID: 33950182
    [Abstract] [Full Text] [Related]

  • 9. [Translated article] Physicochemical and microbiological stability study of two new preservative-free methylprednisolone eye drops.
    Merino-Bohórquez V, Berisa-Prado S, Delgado-Valverde M, Tirado-Pérez MJ, García-Palomo M, Alonso-Herreros JM, Cañete-Ramírez C, Dávila-Pousa MD.
    Farm Hosp; 2024 Jul 22; 48(4):T145-T152. PubMed ID: 38782645
    [Abstract] [Full Text] [Related]

  • 10. Physicochemical and microbiological stability study of two new preservative-free methylprednisolone eye drops.
    Merino-Bohórquez V, Berisa-Prado S, Delgado-Valverde M, Tirado-Pérez MJ, García-Palomo M, Alonso-Herreros JM, Cañete-Ramírez C, Dávila-Pousa MD, & Grupo de Trabajo de Farmacotecnia de la Sociedad Española de Farmacia Hospitalaria.
    Farm Hosp; 2024 Jul 22; 48(4):145-152. PubMed ID: 38570209
    [Abstract] [Full Text] [Related]

  • 11. Stability of frozen 1% voriconazole eye-drops in both glass and innovative containers.
    Roche M, Lannoy D, Bourdon F, Danel C, Labalette P, Berneron C, Simon N, Odou P.
    Eur J Pharm Sci; 2020 Jan 01; 141():105102. PubMed ID: 31655210
    [Abstract] [Full Text] [Related]

  • 12. Stability of extemporaneously prepared voriconazole ophthalmic solution.
    Al-Badriyeh D, Li J, Stewart K, Kong DC, Leung L, Davies GE, Fullinfaw R.
    Am J Health Syst Pharm; 2009 Aug 15; 66(16):1478-83. PubMed ID: 19667005
    [Abstract] [Full Text] [Related]

  • 13. Stability of frozen 1% voriconazole ophthalmic solution.
    Amorós-Reboredo P, Bastida-Fernandez C, Guerrero-Molina L, Soy-Muner D, López-Cabezas C.
    Am J Health Syst Pharm; 2015 Mar 15; 72(6):479-82. PubMed ID: 25736943
    [Abstract] [Full Text] [Related]

  • 14. Stability of tacrolimus injection diluted in 0.9% sodium chloride injection and stored in Excel bags.
    Myers AL, Zhang Y, Kawedia JD, Shank BR, Deaver MA, Kramer MA.
    Am J Health Syst Pharm; 2016 Dec 15; 73(24):2083-2088. PubMed ID: 27919876
    [Abstract] [Full Text] [Related]

  • 15. Impact of deep freezing on the stability of 25 mg/ml vancomycin ophthalmic solutions.
    Sautou-Miranda V, Libert F, Grand-Boyer A, Gellis C, Chopineau J.
    Int J Pharm; 2002 Mar 02; 234(1-2):205-12. PubMed ID: 11839451
    [Abstract] [Full Text] [Related]

  • 16. Physical, chemical, and microbiological stability study of diluted atropine eye drops.
    Saito J, Imaizumi H, Yamatani A.
    J Pharm Health Care Sci; 2019 Mar 02; 5():25. PubMed ID: 31844539
    [Abstract] [Full Text] [Related]

  • 17. Stability of extemporaneously prepared ophthalmic solutions for mydriasis.
    Camp NA, Nadra JT, Hughes SE, Gilbert JM, Zhao F.
    Am J Health Syst Pharm; 2018 May 01; 75(9):e231-e235. PubMed ID: 29691266
    [Abstract] [Full Text] [Related]

  • 18. [Galenic and analytic development of tacrolimus 0.06% eye drops].
    Gauthier AS, Rival B, Sahler J, Fagnoni-Legat C, Limat S, Guillaume Y, Delbosc B.
    J Fr Ophtalmol; 2013 May 01; 36(5):408-13. PubMed ID: 23218600
    [Abstract] [Full Text] [Related]

  • 19. Stability Evaluation of Extemporaneously Compounded Vancomycin Ophthalmic Drops: Effect of Solvents and Storage Conditions.
    Ross C, Syed B, Pak J, Jhanji V, Yamaki J, Sharma A.
    Pharmaceutics; 2021 Feb 23; 13(2):. PubMed ID: 33672310
    [Abstract] [Full Text] [Related]

  • 20. Formulation and stability of an extemporaneous 0.02% chlorhexidine digluconate ophthalmic solution.
    Lin SC, Huang CF, Shen LJ, Wang HJ, Lin CY, Wu FL.
    J Formos Med Assoc; 2015 Dec 23; 114(12):1162-9. PubMed ID: 25260549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.